The Kiteworks research reveals that 27% of life organizations acknowledge that more than 30% of their AI-processed data ...

Fresenius announced that its operating company, Fresenius Kabi, has introduced two new biosimilars – Conexxence ...

Dr. Abdul Mutlib is appointed the President of Frontage Laboratories, Canada, and will continue to serve as Chief Scientific ...

Hikma Pharmaceuticals will invest $1 billion by 2030 to further expand its US manufacturing and R&D capabilities.

BioMarin Pharmaceutical Inc. has completed the previously announced agreement to acquire Inozyme Pharma Inc. for $4.00 per ...

It is the only ready-to-use liquid immunoglobulin therapy with (IgA) content and is set for commercialization in 2026.

Veranova has appointed Dr. Matteo Villain as Vice President of Peptides and Oligonucleotides. Villain brings extensive ...

EUROAPI has signed a share purchase agreement (SPA) for the sale of 100% of EUROAPI UK Ltd, with a simultaneous closing to ...

ProFound Therapeutics, a company pioneering the expanded human proteome to develop medicines, has announced a four-year ...

© Vetter Pharma International GmbH: Vetter marks the start of new clinical site construction with groundbreaking ceremony.

Bristol Myers Squibb (BMS) received U.S. Food and Drug Administration (FDA) approval for label updates for its CAR T cell ...

Mabion has partnered with NovalGen to bring the proprietary T-cell engager, NVG-222, to market for phase one of in-human ...